Pay in 4 interest-free payments of $31.24 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
) also suppresses the growth of HeLa cells in SCID mice
H2O/c7-4(8)6(10
Meagher EA
Purmorphamine was used at 2-10 µM final concentration in cell culture
2-dihydro-2
Miglustat Hydrochloride 240551 ) also suppresses the growthMiglustat, also known as OGT 918 and NB DNJ, is a drug developed by Actelion and is used primarily to treat Type I Gaucher disease (GD1). Miglustat inhibits glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids (it forms glucosylceramide and accumulates within the macrophages). Miglustat is used to treat adults with mild to moderate Type I Gaucher disease and it is the first treatment to be approved for patients
US$ 5450.00
US$ 45.00
US$ 1950.00
US$ 2350.00
US$ 175.00
US$ 23750.00
US$ 999.50
US$ 2875.00